tiprankstipranks
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market

Compare Diamedica Therapeutics (DMAC) vs. Competitors

569 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Diamedica Therapeutics
$5.99
$322.76M
-11.41
70.66%
4 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$2.90
$27.21M
-1.38
-80.13%
4 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$31.20
$1.79B
-12.77
251.35%
8 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.49
$380.84M
-2.29
-29.35%
7 Buy
4 Hold
2 Sell
Moderate Buy
Benitec Biopharma
$11.42
$392.33M
-4.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Annexon Biosciences
$5.85
$938.77M
-3.77
323.91%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DMAC
Diamedica Therapeutics
5.99
2.45
69.21%
TVRD
Tvardi Therapeutics
2.90
-13.75
-82.58%
CAPR
Capricor Therapeutics
31.20
21.80
231.91%
RCKT
Rocket Pharmaceuticals
3.49
-2.42
-40.95%
BNTC
Benitec Biopharma
11.42
-1.85
-13.94%
ANNX
Annexon Biosciences
5.85
4.32
282.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts